EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan

Hisanori Kawamoto, Koichiro Tsugawa, Yuko Furuya, Kaori Sakamaki, Sayoko Kakimoto, Mina Kitajima, Mariko Nagai Takishita, Mizuho Tazo, Mari Hara Nakano, Takako Kuroda, Ayaka Shimo, Arata Shimo und 8 weitere

Breast Cancer · 2024

DOI: 10.1007/s12282-024-01584-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer, 2024. Verfasst von Hisanori Kawamoto und 19 weiteren Autor:innen. Beteiligte Einrichtung: Breast and Imaging Center, St. Marianna University School of Medicine, Kawasaki-Shi, Japan. h-kawamoto@marianna-u.ac.jp. Hauptthemen laut MEDLINE: Breast Neoplasms, Cryosurgery, Quality of Life, Patient Satisfaction. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ultrasound-guided percutaneous cryoablation (PCA) for early-stage breast cancer (ESBC) can be performed under local anesthesia in an outpatient clinic. This study continues a pilot stage to examine local control, safety, patient quality of life (QoL), satisfaction and cosmetic outcomes of cryoablation for ESBC.

Methods

PCA was performed under local anesthesia for patients with primary ESBC, followed by radiation and endocrine therapies. Oncologic outcomes were examined by imaging (mammography, ultrasound, MRI) at baseline and 1, 6, 12, 24, 36, and 60 months post-cryoablation. EQ-VAS, EQ-5D-5L, subjective satisfaction and Moiré topography were used to measure health-related QoL outcomes.

Results

Eighteen patients, mean aged 59.0 ± 9.0 years, mean tumor size 9.8 ± 2.3 mm, ER + , PR + (17/18), HER2-, Ki67 < 20% (15/18), underwent PCA and were followed for a mean of 44.3 months. No serious adverse events were reported, and no patients had local recurrence or distant metastasis in the 5-year follow-up. Cosmetic outcomes, satisfaction level, and QoL all improved post-cryoablation. Five-year average reduction rates of the cryolesion long, short, and depth diameters, on US, were 61.3%, 42.3%, and 22.8%, respectively, compared to the 86.2% volume reduction rate on MRI. The correlation coefficient between MRI and US measurement criteria was highest for the long diameter. During follow-up, calcification of the treated area was observed in 13/18 cases.

Conclusion

Cryoablation for ESBC is an effective and safe procedure with excellent cosmetic outcomes and improved QoL. This study contributes to the growing evidence supporting cryoablation as a potential standard treatment for ESBC, given compliance to pre-defined patient selection criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCryosurgeryQuality of LifePatient SatisfactionHumansFemaleMiddle AgedFollow-Up StudiesAgedJapanUltrasonography, InterventionalTreatment OutcomePilot ProjectsNeoplasm StagingAdult

Stichwörter der Autor:innen

Breast cancerCryoablationCryotherapyNonsurgical ablationOutpatient procedure

Autor:innen und Institutionen

  • Breast and Imaging Center, St. Marianna University School of Medicine, Kawasaki-Shi, Japan. h-kawamoto@marianna-u.ac.jp.
  • Department of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki-Shi, Japan. h-kawamoto@marianna-u.ac.jp.
  • Breast and Imaging Center, St. Marianna University School of Medicine, Kawasaki-Shi, Japan.
  • Department of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki-Shi, Japan.
  • Department of Diagnostic and Interventional Radiology, St. Marianna University School of Medicine, Kawasaki-Shi, Japan.

Zitieren

APA

Kawamoto, H., Tsugawa, K., Furuya, Y., Sakamaki, K., Kakimoto, S., Kitajima, M., Takishita, M. N., Tazo, M., Nakano, M. H., Kuroda, T., Shimo, A., Shimo, A., Kojima, Y., Tsuzuki, M., Motoyoshi, A., Haku, E., Nishikawa, T., Kanemaki, Y., Mimura, H., & Fukuda, M. (2024). Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan. Breast Cancer. https://doi.org/10.1007/s12282-024-01584-4

Vancouver

Kawamoto H, Tsugawa K, Furuya Y, Sakamaki K, Kakimoto S, Kitajima M, et al. Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan. Breast Cancer. 2024. doi:10.1007/s12282-024-01584-4

BibTeX
@article{Kawamoto2024,
  author = {Kawamoto, Hisanori and Tsugawa, Koichiro and Furuya, Yuko and Sakamaki, Kaori and Kakimoto, Sayoko and Kitajima, Mina and Takishita, Mariko Nagai and Tazo, Mizuho and Nakano, Mari Hara and Kuroda, Takako and Shimo, Ayaka and Shimo, Arata and Kojima, Yasuyuki and Tsuzuki, Makiko and Motoyoshi, Ai and Haku, Ei and Nishikawa, Toru and Kanemaki, Yoshihide and Mimura, Hidefumi and Fukuda, Mamoru},
  title = {Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan},
  journal = {Breast Cancer},
  year = {2024},
  doi = {10.1007/s12282-024-01584-4}
}
Kostenlos starten →